Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461

PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES

Dulbecco, R., & Vogt, M. (1954) · The Journal of Experimental Medicine · doi:10.1084/jem.99.2.167 · Cited by 3,837

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224

The NCI60 human tumour cell line anticancer drug screen

Shoemaker, R. H. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1951 · Cited by 2,673

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279

A small-cell lung cancer genome with complex signatures of tobacco exposure

Pleasance, E., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A. M., Jones, D., Lin, M., Beare, D. M., Lau, K. W., Greenman, C., et al. (2009) · Nature · doi:10.1038/nature08629 · Cited by 1,076

p53 mutations in colorectal cancer.

Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,002

Untitled work

(1952) · Cancer Research · Cited by 987

The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer

Asare-Werehene, M., Hunter, R., Gerber, E., Reunov, A., Brine, I., Chang, C.-Y., Chang, C., Shieh, D., Burger, D. E., Anis, H., et al. (2023) · Cancers · doi:10.3390/cancers15092566 · Cited by 14

Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer

Nguyen, P. M., Dagley, L. F., Preaudet, A., Lam, N., Giam, M., Fung, K. Y., Aizel, K., van Duijneveldt, G., Tan, C. W., Hirokawa, Y., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0383-9 · Cited by 15

Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription

Zheng, J.-J., He, Y., Liu, Y., Li, F.-S., Cui, Z. Y., Du, X., Wang, C., & Wu, Y. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01580-w · Cited by 14

Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells

Zhao, Y., Zhou, K., Xia, X., Guo, Y., & Li, T. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2111769 · Cited by 14

CMTM6 attenuates cisplatin‐induced cell death in OSCC by regulating AKT/c‐Myc ‐driven ribosome biogenesis

Mohapatra, P., Mohanty, S., Ansari, S. A., Shriwas, O., Ghosh, A., Rath, R., Majumdar, S. K. D., Swain, R. K., Raghav, S. K., & Dash, R. (2022) · The FASEB Journal · doi:10.1096/fj.202200808rr · Cited by 14

Anti-Apoptotic Effects of Docosahexaenoic Acid in IL-1β-Induced Human Chondrosarcoma Cell Death through Involvement of the MAPK Signaling Pathway

Xu, F., Song, Y., & Guo, A. (2019) · Cytogenetic and Genome Research · doi:10.1159/000500290 · Cited by 14

An Organic–Inorganic Hybrid Nanocomposite as a Potential New Biological Agent

Dulski, M., Malarz, K., Kuczak, M., Dudek, K., Matus, K., Sułowicz, S., Mrozek‐Wilczkiewicz, A., & Nowak, A. (2020) · Nanomaterials · doi:10.3390/nano10122551 · Cited by 14

Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women

Floris, M., Pira, G., Castiglia, P., Idda, M. L., Steri, M., Miglio, M. R. D., Piana, A. F., Cossu, A., Azara, A., Arru, C., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13451 · Cited by 12

Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

Lee, K., Choi, Y., Lim, H.-I., Cho, K.-J., Kang, N., & Ko, S. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04347-y · Cited by 13

Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells

Wiesmann, N., Gieringer, R., Grus, F. H., & Brieger, J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.10.015 · Cited by 13

Extracellular Vesicle Mediated Tumor-Stromal Crosstalk Within an Engineered Lung Cancer Model

Goliwas, K. F., Ashraf, H. M., Wood, A. M., Wang, Y., Hough, K. P., Bodduluri, S., Athar, M., Berry, J. L., Ponnazhagan, S., Thannickal, V. J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.654922 · Cited by 13

MicroRNA-324-5p–CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness

Ghatak, D., Datta, A., Roychowdhury, T., Chattopadhyay, S., & Roychoudhury, S. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0717 · Cited by 13

Regulation of the Soluble Amyloid Precursor Protein α (sAPPα) Levels by Acetylcholinesterase and Brain-Derived Neurotrophic Factor in Lung Cancer Cell Media

Khashali, H. A., Ray, R., Coleman, K.-L., Atali, S., Haddad, B., Wareham, J., Guthrie, J. W., Heyl, D., & Evans, H. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810746 · Cited by 13

11‐Cl‐BBQ , a select modulator of AhR ‐regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27 Kip1

Nguyen, B. D., Stevens, B. L., Elson, D. J., Finlay, D., Gamble, J. T., Kopparapu, P., Tanguay, R. L., Buermeyer, A. B., Kerkvliet, N. I., & Kolluri, S. K. (2022) · FEBS Journal · doi:10.1111/febs.16683 · Cited by 12

5-aza-2′,2′-Difluoro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer

Daifuku, R., Hu, Z., & Saunthararajah, Y. (2017) · Pharmaceuticals · doi:10.3390/ph10030065 · Cited by 12

Characterization of the mutational profile of 11 diffuse large B-cell lymphoma cell lines

Juškevičius, D., Mueller, A., Hashwah, H., Lundberg, P., Tzankov, A., & Menter, T. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1387903 · Cited by 12

S100A1 blocks the interaction between p53 and mdm2 and decreases cell proliferation activity

Dowarha, D., Chou, R., & Yu, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234152 · Cited by 12

Non-targeting control for MISSION shRNA library silences SNRPD3 leading to cell death or permanent growth arrest

Czarnek, M., Sarad, K., Karaś, A., Kochan, J. A., & Bereta, J. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.004 · Cited by 12

Regulation of Soluble E-Cadherin Signaling in Non-Small-Cell Lung Cancer Cells by Nicotine, BDNF, and β-Adrenergic Receptor Ligands

Ray, R., Goel, S., Khashali, H. A., Darweesh, B., Haddad, B., Wozniak, C., Ranzenberger, R., Khalil, J., Guthrie, J. W., Heyl, D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092555 · Cited by 11

Regulation of Vascular Endothelial Growth Factor Signaling by Nicotine in a Manner Dependent on Acetylcholine-and/or β-Adrenergic-Receptors in Human Lung Cancer Cells

Khashali, H. A., Darweesh, B., Ray, R., Haddad, B., Wozniak, C., Ranzenberger, R., Goel, S., Khalil, J., Guthrie, J. W., Heyl, D., et al. (2023) · Cancers · doi:10.3390/cancers15235500 · Cited by 11

The oncogenic ADAMTS1–VCAN–EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma

Wen, Y., Lin, Y., Ho, K., Yang, Y., Lai, F.-R., Chu, C., Chen, J., Lee, W.-J., & Chien, M. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00643-0 · Cited by 12

RNA Sequencing of Hepatobiliary Cancer Cell Lines: Data and Applications to Mutational and Transcriptomic Profiling

Scherer, D., López, M. D., Goeppert, B. F., Abrahamsson, S., Silos, R. G., Nova, I., Marcelain, K., Roa, J. C., Ibberson, D., Umu, S. U., et al. (2020) · Cancers · doi:10.3390/cancers12092510 · Cited by 11

The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches

Arabpour, M., Layeghi, S. M., Tavakkoly‐Bazzaz, J., Naghizadeh, M. M., Majidzadeh‐A, K., & Shakoori, A. (2021) · Human Cell · doi:10.1007/s13577-021-00539-7 · Cited by 11

Cyclin-dependent kinase 2 inhibitor SU9516 increases sensitivity of colorectal carcinoma cells Caco-2 but not HT29 to BH3 mimetic ABT-737

Štefaniková, A., Klačanová, K., Pilchová, I., Hatok, J., & Račay, P. (2017) · General Physiology and Biophysics · doi:10.4149/gpb_2017030 · Cited by 11

Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer

Silva, V. L., Saxena, J., Nicolini, F., Hoare, J. I., Metcalf, S., Martin, S. A., & Lockley, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03665-0 · Cited by 10

Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol

Chitre, S., Ray, A., Stevens, M., Doud, E. H., Liechty, H., Washburn, A., Tepper, K. R., Sivinski, J., O’Hagan, H. M., Georgiadis, M. M., et al. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117072 · Cited by 10

Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion

Guo, A. K., Itahana, Y., Seshachalam, V. P., Chow, H. Y., Ghosh, S., & Itahana, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01124-9 · Cited by 10

Opposing Roles of IGFBP-3 and Heparanase in Regulating A549 Lung Cancer Cell Survival

Khashali, H. A., Wareham, J., Ray, R., Haddad, B., Coleman, K.-L., Ranzenberger, R., McCombs, P., Guthrie, J. W., Heyl, D., & Evans, H. G. (2022) · Cells · doi:10.3390/cells11223533 · Cited by 9

Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines

Min, D.-J., Zhao, Y., Monks, A. P., Palmisano, A., Hose, C. D., Teicher, B. A., Doroshow, J. H., & Simon, R. M. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03898-z · Cited by 9

Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo

Klimovich, B., Stiewe, T., & Timofeev, O. N. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1693748 · Cited by 9

Regulation of DNA damage response by trimeric G-proteins

El‐Hafeez, A. A. A., Sun, N. N., Chakraborty, A., Ear, J., Roy, S., Chamarthi, P., Rajapakse, N., Das, S., Luker, K. E., Hazra, T. K., et al. (2023) · iScience · doi:10.1016/j.isci.2023.105973 · Cited by 8

Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation

Liu, R., Wei, W., Hou, H., Cong, P., Zhou, Y., & Yu, X. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s362185 · Cited by 8

Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance

Kashofer, K., Regauer, S., Reich, O., Petru, E., & Winter, E. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.01.020 · Cited by 7

Comparative Analysis of Transcriptional Responses to Genotoxic and Non-Genotoxic Agents in the Blood Cell Model TK6 and the Liver Model HepaRG

Kreuzer, K., Sprenger, H., & Braeuning, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073420 · Cited by 7

Single Cell Detection of the p53 Protein by Mass Cytometry

Fagerholt, O. H. E., Hellesøy, M., Gullaksen, S., & Gjertsen, B. T. (2020) · Cancers · doi:10.3390/cancers12123699 · Cited by 7

Fucoxanthinol Promotes Apoptosis in MCF-7 and MDA-MB-231 Cells by Attenuating Laminins–Integrins Axis

Yasuda, A., Wagatsuma, M., Murase, W., Kubota, A., Kojima, H., Ohta, T., Hamada, J., Maeda, H., & Terasaki, M. (2022) · Onco · doi:10.3390/onco2030010 · Cited by 7

Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

Brainson, C. F., Xu, C., Desai, P. T., Berry, J. M., Rowbotham, S. P., Lin, Y.-J., Zhang, H., Márquez, V. E., Hammerman, P. S., Wong, K., et al. (2018) · Nature · doi:10.1038/s41586-018-0580-6 · Cited by 7

Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis

Tomas, E. J., Valdés, Y. R., Davis, J., Kolendowski, B., Buensuceso, A. V., DiMattia, G. E., & Shepherd, T. G. (2025) · Cells · doi:10.3390/cells14020133 · Cited by 7

Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming

Ma, L., Zheng, H., Xie, W., Sun, W., Yuan, Q., Song, K., Xi, P., Qu, F., & Zhang, H. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.139625 · Cited by 7

Hellebrigenin triggers death of promyelocytic leukemia cells by non-genotoxic ways

Cavalcanti, B. C., Soares, B. M., Barreto, F. S., Magalhães, H. I. F., Ferreira, J. R. D. O., de Almeida, A. T. A., Filho, J. I. A. B., Silva, J., Silva, J., dos Santos, H. S., et al. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107591 · Cited by 6

The CDK 12– BRCA 1 signaling axis mediates dinaciclib‐associated radiosensitivity through p53‐mediated cellular senescence

García-Flores, N., Fernández‐Aroca, D. M., Garnés‐García, C., Domínguez‐Calvo, A., Jiménez‐Suárez, J., Sabater, S., Fernández‐Aroca, P., Andrés, I., Cimas, F. J., de Cárcer, G., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13773 · Cited by 8

7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties

Górecki, L., Muthná, D., Merdita, S., Andrš, M., Kucera, T., Havelek, R., Múčková, Ľ., Kobrlová, T., Soukup, J., Krůpa, P., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114580 · Cited by 7

Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites

Ilic, A., Lu, S., Bhatia, V., Begum, F., Klonisch, T. C., Agarwal, P., Xu, W. W., & Davie, J. R. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0160-2 · Cited by 6

Discovery of Survivin Inhibitors Part 1: Screening the Harbor Branch Pure Compound Library

Guzmán, E. A., Pitts, T. P., Francis, K. T., Winder, P. L., & Wright, A. E. (2021) · Marine Drugs · doi:10.3390/md19020073 · Cited by 6

CHIP suppresses the proliferation and migration of A549 cells by mediating the ubiquitination of eIF2α and upregulation of tumor suppressor RBM5

Jin, B., Wang, M., Sun, Y., Lee, P. A. H., Zhang, X., Lu, Y., & Zhao, B. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105673 · Cited by 5

Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation

Kwan, K., Castro-Sandoval, O., Ma, B. N., Martelino, D., Saffari, A., Liu, X. L., Orvain, C., Mellitzer, G., Gaiddon, C., & Storr, T. (2023) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2023.112433 · Cited by 5

Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer

Cheng, Z., Guo, Y., Sun, J., & Zheng, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-17927-0 · Cited by 5

Adrenergic signals influence proteomic responses in breast cancer cells

Carrasco, M., Bjørnstad, O. V., Vethe, H., & Akslen, L. A. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1608017 · Cited by 4

Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells

Osborne, H. C., Larrosa, I., & Schmidt, C. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031116 · Cited by 4

Syntheses and antitumor activities of neorautenol and shinpterocarpin analogs

Huang, G., Hoang, V.-H., Min, H., Lee, H., Ann, J., & Lee, J. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129353 · Cited by 4

The Effect of Bacterial Peptide p28 on Viability and Apoptosis Statusof P53-null HeLa Cells

Abuei, H., Behzad‐Behbahani, A., Faghihi, F., Farhadi, A., Dehbidi, G. R., Pirouzfar, M., & Zare, F. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.078 · Cited by 4

Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition

Lau, T., May, C. M., Dashti, Z. J. S., Swanson, L., Starks, E. R., Parker, J., Moore, R. A., Tucker, T., Bosdet, I., Young, S. S., et al. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.06.006 · Cited by 4

No Intercellular Regulation of the Cell Cycle among Human Cervical Carcinoma HeLa Cells Expressing Fluorescent Ubiquitination-Based Cell-Cycle Indicators in Modulated Radiation Fields

Fukunaga, H., Kaminaga, K., Hirose, E., Watanabe, R., Usami, N., Prise, K. M., & Yokoya, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312785 · Cited by 4

The role of leptin in regulation of the soluble amyloid precursor protein α (sAPPα) levels in lung cancer cell media

Haddad, B., Khalil, J., Khashali, H. A., Ray, R., Goel, S., Darweesh, B., Coleman, K.-L., Wozniak, C., Ranzenberger, R., Lopo, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55717-y · Cited by 4

Zebrafish embryonic development-interfering macrolides from Streptomyces californicus impact growth and mitochondrial function in human colorectal cancer cells

Tan, P. J., Lau, B. F., Krishnasamy, G., Ng, M. F., Husin, L. S., Ruslan, N. F., Song, D. S. S., Velaithan, V., Okuda, K. S., & Patel, V. (2018) · Process Biochemistry · doi:10.1016/j.procbio.2018.07.007 · Cited by 4

Unveiling the Role of CCL3: A Driver of CIPN in Colon Cancer Patients?

Luzac, I., Regalado, C. R., & Balogh, M. (2025) · Biomedicines · doi:10.3390/biomedicines13102512 · Cited by 4

BMP Stimulation Differentially Affects Phosphorylation and Protein Stability of β-Catenin in Breast Cancer Cell Lines

Ilhan, M., Haştar, N., Kampfrath, B., Spierling, D. N., Jatzlau, J., & Knaus, P. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094593 · Cited by 5

Role of tumor suppressor genes P53 and PTEN in CD44-mediated gastric adenocarcinoma multidrug resistance

Perez‐Silva, L., Herráez, E., Marijuan, R. P., Reviejo, M., Lozano, E., Bujanda, L., Abad, M., Macı́as, R. I. R., Briz, Ó., & Marı́n, J. J. G. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118057 · Cited by 3

Mechanistic insight into anaphase bridge signaling to the abscission checkpoint

Singh, M. I., Rajendraprasad, G., Katopodis, V., Cui, R., Barišić, M., Bhowmick, R., & Hickson, I. D. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00453-w · Cited by 3

The miR ‐29 family members induce glioblastoma cell apoptosis by targeting cell division cycle 42 in a p53‐dependent manner

Shi, C., Luo, W., Sun, C., Yu, L., Zhou, X., Hua, D., Jiang, Z., Wang, Q., & Yu, S. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.13964 · Cited by 3

Haberlea rhodopensis alcohol extract normalizes stress-responsive transcription of the human TP53 gene

Dimitrova, N., Staneva, D., Popov, B. N., Alexandrova, A., Georgieva, M., & Miloshev, G. A. (2023) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2023.11(2).405.415 · Cited by 3

NOTCH2 gene mutation and gamma-secretase inhibitor in mediating the malignancy of ovarian cancer

Wang, W., Liu, R., Liao, W., Ji, L., Mei, J., & Su, D. (2023) · Aging · doi:10.18632/aging.205045 · Cited by 3

Li-Fraumeni syndrome: a germline TP53 splice variant reveals a novel physiological alternative transcript

Louis, J., Rolain, M., Levacher, C., Baudry, K., Pujol, P., Ruminy, P., Baert‐Desurmont, S., Bou, J., Bouvignies, E., Coutant, S., et al. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110449 · Cited by 2

Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensitivity status in high grade serous ovarian cancer

Jansen, C., McAdams, J. N., Kim, C., Cruz, P. D. L., Salaverria, A., DaSilva, N. A., Grive, K. J., & James, N. E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1547164 · Cited by 3

The G199X and V157fs mutations in the TP53 gene promote malignancy in serous ovarian cancer: an analysis using whole-exome sequencing

Su, D., Nie, M., & Yue, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-583 · Cited by 3

Optimization of PEGylation for cationic triacyl lipid-based siRNA lipoplexes prepared using the modified ethanol injection method for tumor therapy

Hattori, Y., Shinkawa, M., Kurihara, A., & Shimizu, R. (2025) · Journal of Liposome Research · doi:10.1080/08982104.2025.2498956 · Cited by 2

Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer Agents

Mansour, M. A., Hassan, G. S., Jaballah, M. Y., Serya, R. A. T., Dege, N., Şahın, O., Sharaky, M. M., Zhang, X., Su, R., De, K., et al. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70085 · Cited by 2

Lunatin-1: a membrane-disruptive peptide isolated from Hadruroides lunatus scorpion venom with cytotoxicity against MDA-MB-231 breast cancer cell line

Gomes, K. D. S., Raíssa‐Oliveira, B., Schildknecht, S., de Lima, M. E., Melo‐Braga, M. N., Gomes, D. A., Pimenta, A. M. C., Verano‐Braga, T., Leist, M., & de Souza-Fagundes, E. M. (2025) · Biochimie · doi:10.1016/j.biochi.2025.06.006 · Cited by 2

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer ( NSCLC ) cell culture supernatants, inhibiting cell survival

Goel, S., Wozniak, C., Sabri, A., Haddad, B., Lopo, B., Cobos, A., Sarofim, S., Guthrie, J. W., Heyl, D., & Evans, H. G. (2025) · FEBS Open Bio · doi:10.1002/2211-5463.70125 · Cited by 2

Silencing of Nucleostemin by siRNA Induces Apoptosis in MCF-7 and MDA-MB-468 Cell Lines.

Moudi, M., Saravani, R., & Sargazi, S. (2020) · PubMed Central · doi:10.22037/ijpr.2020.1100950 · Cited by 2

Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic Cells

Thadi, A., LEWIS, L., Goldstein, E., Aggarwal, A., Khalili, M., Steele, L. A., Polyak, B., Seydafkan, S., Bluth, M. H., Ward, K. M., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14488 · Cited by 2

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis

Satta, N., Weppe, R., Pagano, S., Frias, M. A., Juillard, C., & Vuilleumier, N. (2020) · Oncotarget · doi:10.18632/oncotarget.27814 · Cited by 2

A CRISPR-Cas9 Genome Engineering Platform in Primary CD4+ T Cells for the Interrogation of HIV Host FactorsPreprint

Hultquist, J. F., Hiatt, J. B., Schumann, K., McGregor, M., Roth, T. L., Haas, P., Doudna, J. A., Marson, A., & Krogan, N. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/205500 · Cited by 2

Both DNA binding domains of p53 are required for its ultra-rapid recruitment to sites of UV damagePreprint

Wang, Y., Ho, T., Hariharan, A., Goh, H., Sheetz, M., & Lane, D. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.09.938993 · Cited by 2

TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effectsPreprint

Ragu, M. E., Lim, J., Ng, P.-S., Yip, C. H., Rajadurai, P., Teo, S., & Pan, J. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.31.486643 · Cited by 2

Single cell CRISPR base editor engineering and transcriptional characterization of cancer mutationsPreprint

Kim, H. S., Grimes, S. M., Sathe, A., Lau, B. T., & Ji, H. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.31.514258 · Cited by 2

The Intrabody Against Murine Double Minute 2 via a p53-Dependent Pathway Induces Apoptosis of Cancer Cell

Wang, C., Liu, W.-T., Guo, H., Lan, T., Wang, T., & Wang, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115286 · Cited by 1

Mechanisms and Ways to Overcome Acquired Resistance of Cancer Cells to Mcl-1 Antagonists

Pervushin, N. V., Fernandez, B. Y. V., Senichkin, V. V., Yapryntseva, M. A., Pavlov, V., Zhivotovsky, B., & Kopeina, G. S. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297925602710 · Cited by 1

In vitro and in vivo antitumor activity of Laz-expressing Salmonella Typhimurium YB1 via optimized secretion and regulation

Abouelenen, Y. I., Ramzy, R. M., El-Bahy, A. A. Z., Riedel, C. U., Abou-Aisha, K. M., & Mansour, M. (2026) · AMB Express · doi:10.1186/s13568-026-02057-x · Cited by 1

GPR19 Drives Cell Cycle Progression via ERK-Dependent FOXM1 Activation in p53-Mutant Breast Cancer

Qiu, J., Tian, C., Li, H., Gao, S., Yang, C., Luo, Q., Liu, Y., He, K., Li, K., Peng, Y., et al. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl52064 · Cited by 1

Caspase-independence and characterization of bisnaphthalimidopropyl spermidine induced cytotoxicity in HL60 cells

Bestwick, C. S., Milne, L., Dance, A.-M., Cochennec, G., Cruickshank, G., Allain, E., Constable, L., Duthie, S. J., & Lin, P. K. T. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.06.023 · Cited by 1

Evaluation of Cell Cycle-Dependent Migration Activity after X-ray Exposure: A Radiobiological Approach for Optimization of Radiotherapy with Cell Cycle-Targeting Agents

Seino, R., & Fukunaga, H. (2024) · Radiation Research · doi:10.1667/rade-23-00213.1 · Cited by 1

Physical Exercise and Gene p53—A Mini Review

Cabral, T. H., Lozinski, A. L., Tanaka, G. M., Cardoso, M. A., Simeoni, R. B., Gomes, P. V., Netto, Z. C. O., Guarita-Souza, L. C., Francisco, J. C., & da Cunha, R. C. (2020) · Journal of Cancer Therapy · doi:10.4236/jct.2020.118039 · Cited by 1

Preconditioning with Near-Infrared Irradiation to Enhance the Irreversible Electroporation Efficiency in HeLa Cells

Kim, H. B., Jeong, S. J., & Baik, K. Y. (2021) · Applied Sciences · doi:10.3390/app11188504 · Cited by 1

Regulation of DNA damage response by trimeric G-protein SignalingPreprint

El‐Hafeez, A. A. A., Sun, N. N., Chakraborty, A., Ear, J., Roy, S., Chamarthi, P., Rajapakse, N., Das, S., Luker, K. E., Hazra, T. K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.21.452842 · Cited by 1

Faculty Opinions recommendation of Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.

Lees‐Miller, S. P. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732976037.793546302 · Cited by 1

Investigating the impact of NRMT1 cancer mutants on catalytic specificity and the DNA damage response.

Shields, K. M. (2018) · doi:10.18297/etd/3034

In Vitro Evaluation of Ovarian Cancer Tumorigenesis as a Function of Quinone Oxidoreducatse-1 and Cell Phenotype

Jackson, M. S. (2019) · doi:10.31390/gradschool_dissertations.4968

Discovery and characterization of quadruplex remodeling proteins

McRae, E. K. S. (2019) · Mspace (University of Manitoba)

Pathogenic somatic alterations in advanced HPV-negative cell squamous laryngeal carcinoma revealed via targeted next generation sequencing

Kyurkchiyan, S. G., Popov, T. M., Kachakova, D., Mihova, K. Y., Petkova, V., Rangachev, J., Mitev, V., Popova, D. P., & Kaneva, R. P. (2020) · Genetika · doi:10.2298/gensr2002477k

Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage

Haider, N. (2018) · TSpace (University of Toronto)

CANCER: EFFECT OF CHEMOTHERAPEUTIC AGENTS ON DSC3 EXPRESSION

Shukla, C. P., a, N. K. J., Modi, R. I., & b, B. K. (2021) · Journal of Bio Innovation · doi:10.46344/jbino.2021.v010i01.28

Association Between Arg72Pro Polymorphism in TP53 and Malignant Abdominal Solid Tumor Risk in Hunan Children

Liu, Z., Xiao, Z., Li, M., Xiao, Y., Wang, X., He, J., & Li, Y. (2021) · Cancer Control · doi:10.1177/10732748211004880

SKIRTINGŲ KRŪTIES VĖŽIO LĄSTELIŲ LINIJŲ ATSPARUMO RADIOTERAPIJAI TYRIMAS

Laukaitienė, D., Vaitkus, A., Savukaitytė, A., Vadeikienė, R., Inčiūra, A., Ugenskienė, R., & Juozaitytė, E. (2021) · Health Sciences · doi:10.35988/sm-hs.2021.085

La imagen corporalizada

Sardo, D. (2005) · Cuadernos del IVAM

Charakterisierung des NF-κB Signalwegs in Arid1a defizienten Pankreaskarzinomsubtypen

Aperdannier, L. (2021) · doi:10.53846/goediss-8735

Genome Instability and Pressure on Non-Homologous end Joining drives Chemotherapy Resistance via a DNA Repair Crisis Switch in Triple Negative Breast Cancer.Preprint

Wiegmans, A. P., Ward, A., Ivanova, E., Duijf, P. H. G., VanOosterhout, R., Sadowski, M. C., Kelly, G., Morrical, S. W., Lee, J. S., & Richard, D. J. (2020) · doi:10.21203/rs.3.rs-103661/v1

Pathogenetic value of TP53 point mutations in adult acute myeloid leukemia patients

Vinogradov, A. V., Rezaykin, A. V., Литвинова, Д. В., Loboda, A., Sazonov, S. V., & Sergeev, A. G. (2020) · Russian Journal of Immunology · doi:10.46235/1028-7221-264-pvo

The kinetics and fragmentation of cell-free DNA from cultured cancer cells are influenced by anticancer treatmentsPreprint

Bustamante, P., Abdouh, M., Tsering, T., & Burnier, J. V. (2022) · Research Square · doi:10.21203/rs.3.rs-1891499/v1

The role of SRSF6 in the alternative splicing response to hypoxia

Stahl, C. F. (2020) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.70296

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

Berglind, H., Yudi Pawitan, Y., Kato, S., Ishioka, C., & Soussi, T. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.5.5712 · Cited by 102

[Characterization of TP53, APC, and PTEN mutational statuses of 120 human cancer cell lines by using yeast-based analyses].

Suzuki, G. (2003) · PubMed · Cited by 3

MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancera

Soussi, T., Hamroun, D., Hjortsberg, L., Rubio-Nevado, J. M., Fournier, J. L., & Béroud, C. (2010) · Human Mutation · doi:10.1002/humu.21313 · Cited by 27

The TP53 website: An integrative resource centre for the TP53 mutation database and TP53 mutant analysis

Leroy, B., Fournier, J. L., Ishioka, C., Monti, P., Inga, A., Fronza, G., & Soussi, T. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1033 · Cited by 185

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines

Liu, Y., & Bodmer, W. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510146103 · Cited by 257